Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2030?

Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2030? It is currently trading at a 49% probability on Kalshi. Scheduled resolution: January 1, 2032.

Last updated October 16, 2026 at 7:15 PM ET

Current Market Probability

Probability Price Platform Status Resolution date Chart
49% 0.49 Kalshi Open January 01, 2032 View chart

Market Information

Historical Market Probability

7 days ago 30 days ago Current
49% 49% 49%

Related Prediction Markets

Popular Prediction Markets